Cefmatilen
![]() | |
| Clinical data | |
|---|---|
| Routes of administration | Oral |
| ATC code | none |
| Identifiers | |
| |
| CAS Number |
140128-74-1 154776-45-1 (HCl · H2O) |
| PubChem (CID) | 9690121 |
| ChemSpider |
4912110 |
| UNII |
T750UM24H8 |
| ChEMBL | CHEMBL2104438 |
| Chemical and physical data | |
| Formula | C15H14N8O5S4 |
| Molar mass | 514.582 g/mol |
| 3D model (Jmol) | Interactive image |
| |
| |
| (verify) | |
Cefmatilen (INN, codenamed S-1090) is an orally-active cephalosporin antibiotic. It was developed in Japan and first described in 1992.[1]
In vitro, cefmatilen is highly active against a variety of Gram-positive and Gram-negative bacteria, including Streptococcus pyogenes and Neisseria gonorrhoeae.[1]
References
- 1 2 Tsuji M, Ishii Y, Ohno A, Miyazaki S, Yamaguchi K (November 1995). "In vitro and in vivo antibacterial activities of S-1090, a new oral cephalosporin". Antimicrob Agents Chemother. 39 (11): 2544–51. doi:10.1128/aac.39.11.2544. PMC 162981
. PMID 8585742.
Further reading
- Cazzola M (February 2000). "Novel oral cephalosporins". Expert Opin Investig Drugs. 9 (2): 237–46. doi:10.1517/13543784.9.2.237. PMID 11060674.
This article is issued from Wikipedia - version of the 5/25/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
